IMMUNIC, INC.
IMUXNasdaq
$15.16
↑ +0.9%Jul 17 close · end-of-day
Price
1Y↑ +69.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$456.9M
Enterprise Value
$270.2M
P/E
18.7
P/S
—
P/B
3.0
EV/EBITDA
—
PEG
—
FCF Yield
-17.8%
Dividend Yield
0.0%
Revenue (TTM)
—
Net Income (TTM)
-$104.3M
Free Cash Flow (TTM)
-$81.4M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-69.0%
ROIC
—
Debt / Equity
—
Net Cash
$186.6M
Return 1Y
+63.0%
Earnings
IMUX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$1.08↓ -57.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$49.0M | -$91.7M | -$119.5M | -$99.2M | -$98.1M | -$103.2M |
| Net income | -$44.0M | -$92.9M | -$120.4M | -$93.6M | -$100.5M | -$97.2M |
| Diluted EPS | -$2.81 | -$3.93 | -$3.78 | -$2.11 | -$1.00 | -$0.62 |
| Operating cash flow | -$46.1M | -$83.2M | -$65.1M | -$70.8M | -$84.8M | -$85.8M |
| Free cash flow | -$46.3M | -$83.3M | -$65.3M | -$71.2M | -$85.0M | -$86.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$22.8M | -$25.7M | -$25.6M | -$26.8M | -$27.1M | -$26.0M | -$23.3M | -$33.2M |
| Net income | -$21.4M | -$24.4M | -$25.2M | -$25.5M | -$26.8M | -$25.6M | -$19.3M | -$32.6M |
| Diluted EPS | -$0.21 | -$0.24 | -$0.25 | -$2.51 | -$0.20 | -$0.13 | $2.22 | -$1.08 |
| Operating cash flow | -$17.0M | -$20.8M | -$23.0M | -$21.8M | -$24.6M | -$20.1M | -$19.3M | -$17.3M |
| Free cash flow | -$17.2M | -$20.8M | -$23.0M | -$21.8M | -$24.6M | -$20.2M | -$19.3M | -$17.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Coming soonHeadlines for IMUX will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.